Literature DB >> 19494854

The current classification of urothelial neoplasms.

David J Grignon1.   

Abstract

The classification of urothelial neoplasms has been a subject of significant controversy and debate over the last decade. Only recently has a general level of agreement developed on the utility of the classification first proposed by the World Health Organization and the International Society of Urologic Pathology in 1998. Recent adoption of this scheme in therapeutic guidelines indicates the clinical utility of the system. In this review a brief historical perspective is presented, followed by a review of the classification system, the histological criteria for the specific categories and the clinical significance of these diagnoses.

Entities:  

Mesh:

Year:  2009        PMID: 19494854     DOI: 10.1038/modpathol.2008.235

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  13 in total

1.  Clinicopathological and prognostic significance of EZH2 expression in upper urinary tract carcinoma.

Authors:  Akimasa Hayashi; Teppei Morikawa; Taketo Kawai; Haruki Kume; Shumpei Ishikawa; Yukio Homma; Masashi Fukayama
Journal:  Virchows Arch       Date:  2014-01-21       Impact factor: 4.064

2.  UBE2C is a marker of unfavorable prognosis in bladder cancer after radical cystectomy.

Authors:  Teppei Morikawa; Taketo Kawai; Hiroyuki Abe; Haruki Kume; Yukio Homma; Masashi Fukayama
Journal:  Int J Clin Exp Pathol       Date:  2013-06-15

3.  Intravesical BCG Induces CD4+ T-Cell Expansion in an Immune Competent Model of Bladder Cancer.

Authors:  Max Kates; Thomas Nirschl; Nikolai A Sopko; Hotaka Matsui; Christina M Kochel; Leonardo O Reis; George J Netto; Mohammad Hoque; Noah M Hahn; David J McConkey; Alex S Baras; Charles G Drake; Trinity J Bivalacqua
Journal:  Cancer Immunol Res       Date:  2017-06-06       Impact factor: 11.151

4.  Artificial Intelligence-Based Prognostic Model for Urologic Cancers: A SEER-Based Study.

Authors:  Okyaz Eminaga; Eugene Shkolyar; Bernhard Breil; Axel Semjonow; Martin Boegemann; Lei Xing; Ilker Tinay; Joseph C Liao
Journal:  Cancers (Basel)       Date:  2022-06-26       Impact factor: 6.575

5.  HER2 protein overexpression and gene amplification in upper urinary tract urothelial carcinoma-an analysis of 171 patients.

Authors:  Yuka Sasaki; Takeshi Sasaki; Taketo Kawai; Teppei Morikawa; Keisuke Matsusaka; Akiko Kunita; Haruki Kume; Ichiro Aoki; Yukio Homma; Masashi Fukayama
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

6.  HERV-E-mediated modulation of PLA2G4A transcription in urothelial carcinoma.

Authors:  Darko Gosenca; Ute Gabriel; Annette Steidler; Jens Mayer; Olivia Diem; Philipp Erben; Alice Fabarius; Christine Leib-Mösch; Wolf-Karsten Hofmann; Wolfgang Seifarth
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

7.  Nuclear size measurement for distinguishing urothelial carcinomas from reactive urothelium on tissue sections.

Authors:  Kate Poropatich; Jason C Yang; Rajen Goyal; Vamsi Parini; Ximing J Yang
Journal:  Diagn Pathol       Date:  2016-06-30       Impact factor: 2.644

8.  Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer.

Authors:  Frank Jacobsen; Billurvan Taskin; Nathaniel Melling; Charlotte Sauer; Corinna Wittmer; Claudia Hube-Magg; Martina Kluth; Ronald Simon; Dirk Pehrke; Burkhard Beyer; Thomas Steuber; Imke Thederan; Guido Sauter; Thorsten Schlomm; Waldemar Wilczak; Katharina Möller; Sören A Weidemann; Susanne Burdak-Rothkamm
Journal:  BMC Cancer       Date:  2017-07-26       Impact factor: 4.430

9.  Reinventing diagnostics for personalized therapy in oncology.

Authors:  Diponkar Banerjee
Journal:  Cancers (Basel)       Date:  2010-06-02       Impact factor: 6.639

10.  Major differences in glycosylation and fucosyltransferase expression in low-grade versus high-grade bladder cancer cell lines.

Authors:  Bernadette Ezeabikwa; Nandini Mondal; Aristotelis Antonopoulos; Stuart M Haslam; Yasuyuki Matsumoto; Miguel Martin-Caraballo; Sylvain Lehoux; Msano Mandalasi; Ali Ishaque; Jamie Heimburg-Molinaro; Richard D Cummings; Anthony K Nyame
Journal:  Glycobiology       Date:  2021-12-18       Impact factor: 5.954

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.